The incidence of macrophage activation syndrome in patients with adult-onset Still's disease receiving biological therapy
Not Applicable
- Conditions
- Adult-onset Still's disease
- Registration Number
- JPRN-UMIN000049243
- Lead Sponsor
- Yokohama City University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 439
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Systematic review or meta-analysis articles. (2)Case reports or case series reporting less than 5 cases. (3)The republished research literature is excluded unless the research includes new findings related to adverse events listed in inclusion criteria. (4)Studies with no or insufficient safety results at the time of the literature search. (5)Studies published in languages other than English.
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The primary outcome: The prevalence of MAS will be pooled using random effects model meta-analysis.
- Secondary Outcome Measures
Name Time Method Secondary outcome: The frequency of serious adverse events will be pooled using random effects model meta-analysis.